R2 Technology, Inc.
R2 Technology, Inc., headquartered in California’s Silicon Valley, is a
recognized leader in the development and commercialization of computer aided
detection (CAD), an innovative technology that assists physicians in the
earlier detection of breast cancer, actionable lung nodules and other lung
abnormalities. As a medical software company, R2 Technology is developing
CAD systems for a variety of imaging modalities and disease states.
R2 Technology’s ImageChecker system was the first CAD system approved by the
FDA for use with mammography. Since 1998, the company has received multiple
supplemental approvals for technological and clinical advances and owns or
has exclusive rights in over 120 issued and pending patents worldwide.